-
-
-
-
-
-
-
TG Therapeutics (TGTX) Misses Q4 EPS by 23c, provides guidance
-
-
-
-
-
-
-
TG Therapeutics to Host Conference Call on Third Quarter 2025 Financial Results and Business Update
-
-
-
-
-
-
-
TG Therapeutics (TGTX) Tops Q4 EPS by 7c, provides outlook
-
-
-
-
-
-
-
TG Therapeutics Reports Third Quarter 2024 Financial Results and Raises BRIUMVI® (ublituximab-xiiy) Full Year Revenue Guidance
-
-
-
-
-
-
-
TG Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
-
-
-
-
-
-
-
TG Therapeutics Provides Preliminary Fourth Quarter and Full Year 2023 Net Revenue and 2024 Anticipated Milestones
-
-
-
-
-
-
-
TG Therapeutics (TGTX) Misses Q2 EPS by 10c
-
1,211,591 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

